BioPad
Passive Fetal Movement Monitor
Health Tech & Life Sciences
Non Active, Aug 2018
Company Overview
Snapshot
Founded in January 2005 by Alex Shoenfeld, BioPad operates with 1–10 employees. The company is currently in the Pre-Funding stage.
Business overview
BioPad develops a noninvasive device designed to accurately monitor fetal activity in pregnant women from week 24 through birth. This technology aims to augment clinicians' care by providing a reliable means for expectant mothers to monitor fetal activity at home. The device indicates whether the baby's activity is within a normal range or if fetal movement has declined, serving the digital healthcare, patient remote monitoring, and medical devices sectors, particularly focusing on women's health within the United States market.
Company Intelligence Q&A
- What is BioPad's primary product?
- BioPad's primary product is a noninvasive device that accurately monitors fetal activity in pregnant women from week 24 through birth, providing real-time indications and storing movement history.
- Who founded BioPad?
- BioPad was founded by Alex Shoenfeld, who also serves as the CSO and Director.
- In which year was BioPad founded?
- BioPad was founded in January 2005.
- What is the primary market for BioPad's product?
- BioPad's primary market for its fetal movement monitoring device is the United States.
- What is the current operational status of BioPad?
- BioPad has been non-active since August 2018.